ARMP

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Armata Pharmaceuticals Inc

NYSE MKT | ARMP

8.19

USD

+$0.00

(

+0.00%

)

At Close (As of Oct 22, 2025)

$125.72M

Market Cap

-

P/E Ratio

-1.07

EPS

$3.50

52 Week High

$0.90

52 Week Low

HEALTHCARE

Sector

ARMP Chart

Recent Chart
Price Action

ARMP Technicals

Tags:

ARMP Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $3.8M
Total Revenue $5.2M
Cost Of Revenue $1.3M
Costof Goods And Services Sold $1.3M
Operating Income -$42M
Selling General And Administrative $13M
Research And Development $34M
Operating Expenses $48M
Investment Income Net -
Net Interest Income -$10M
Interest Income $697K
Interest Expense $11M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $1.3M
Income Before Tax -$19M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$19M
Comprehensive Income Net Of Tax -
Ebit -$8.2M
Ebitda -$6.8M
Net Income -$19M

Revenue & Profitability

Earnings Performance

ARMP Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $86M
Total Current Assets $11M
Cash And Cash Equivalents At Carrying Value $9.3M
Cash And Short Term Investments $9.3M
Inventory -
Current Net Receivables $744K
Total Non Current Assets $75M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $10M
Intangible Assets Excluding Goodwill $10M
Goodwill $3.5M
Investments -
Long Term Investments -
Short Term Investments -
Other Current Assets $1.3M
Other Non Current Assets -
Total Liabilities $134M
Total Current Liabilities $48M
Current Accounts Payable $766K
Deferred Revenue -
Current Debt -
Short Term Debt $43M
Total Non Current Liabilities $86M
Capital Lease Obligations $32M
Long Term Debt $55M
Current Long Term Debt $39M
Long Term Debt Noncurrent -
Short Long Term Debt Total $127M
Other Current Liabilities $4.1M
Other Non Current Liabilities -
Total Shareholder Equity -$48M
Treasury Stock -
Retained Earnings -$328M
Common Stock $362K
Common Stock Shares Outstanding $59M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$38M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $1.3M
Capital Expenditures $1.9M
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$1.9M
Cashflow From Financing $35M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$19M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $3.8M
Total Revenue $5.2M
Cost Of Revenue $1.3M
Costof Goods And Services Sold $1.3M
Operating Income -$42M
Selling General And Administrative $13M
Research And Development $34M
Operating Expenses $48M
Investment Income Net -
Net Interest Income -$10M
Interest Income $697K
Interest Expense $11M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $1.3M
Income Before Tax -$19M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$19M
Comprehensive Income Net Of Tax -
Ebit -$8.2M
Ebitda -$6.8M
Net Income -$19M

ARMP Profile

Armata Pharmaceuticals Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Armata Pharmaceuticals Inc. is a clinical-stage biotechnology company based in Marina del Rey, California, focused on developing innovative bacteriophage-based therapies to tackle the escalating threat of antibiotic-resistant infections. By harnessing advanced technologies and deep research expertise, Armata aims to deliver precision medicine solutions that address urgent needs in infectious disease management. The company is building a robust pipeline of therapeutic candidates and establishing strategic collaborations, positioning itself as a key player in the critical fight against antimicrobial resistance and enhancing treatment options for patients worldwide.

YYAI
+88.87%
$0.15
BYND
+14.88%
$4.15
VHAI
0.00%
$0.00
BURU
+26.83%
$0.36
ADAP
+40.53%
$0.06
YDKG
+4.40%
$0.05
F
-1.91%
$12.31
AIRE
+17.02%
$0.85
BENF
+125.66%
$1.09
CGBS
-39.47%
$0.03
DNUT
+13.05%
$4.19
BITF
-15.14%
$3.81
NVDA
-1.95%
$177.61
PLUG
-9.59%
$2.82
RGTI
-12.07%
$35.17
DNN
-2.20%
$2.66
WTO
+5.70%
$0.07
TLRY
-3.06%
$1.43
EPWK
+10.53%
$0.07
CLF
-17.24%
$13.39
AXDX
-61.36%
$0.03
T
-2.40%
$25.42
INTC
-4.61%
$36.36
RANI
-11.22%
$2.52
QBTS
-15.40%
$27.23
BNBX
+47.40%
$5.04
SOFI
-7.37%
$26.63
IXHL
-1.62%
$0.35
RIG
+1.35%
$3.35
TSLA
-2.63%
$430.92
NOK
-1.52%
$5.49
CAN
-12.82%
$1.70
CIFR
-14.77%
$15.40
BBD
-0.45%
$3.28
QUBT
-7.40%
$16.00
ETHD
+10.08%
$4.09
ABEV
-1.35%
$2.19
AMD
-4.45%
$227.43
ONDS
-8.06%
$6.60
IREN
-8.10%
$50.72
PLTR
-5.65%
$171.25
RF
-1.25%
$24.05
GPUS
-3.13%
$0.35
NVTS
-14.87%
$12.79
QS
-13.72%
$13.38
ACHR
-8.80%
$10.40
AAL
-1.98%
$12.10
AREB
+48.40%
$1.85
IONZ
+20.92%
$4.97
RMBL
+60.50%
$3.21
ALEC
-47.81%
$1.67
GPRO
+4.31%
$2.29
NIO
-1.00%
$6.73
GRAB
-1.16%
$5.53
ADD
-25.47%
$0.05
WBD
+1.32%
$20.60
RXRX
-7.20%
$5.67
CJET
+14.21%
$0.09
VALE
+1.92%
$11.48
SRM
+53.27%
$10.30
APLD
-9.37%
$29.49
RR
-15.54%
$4.75
LAES
-14.11%
$5.23
FLWS
-12.33%
$4.51
AVDL
+3.87%
$18.56
SOUN
-6.50%
$17.04
DVLT
-14.82%
$2.15
PFE
-0.52%
$24.72
BTBT
-9.68%
$3.49
MARA
-7.38%
$18.58
CUTR
-10.19%
$0.09
IONQ
-11.17%
$52.85
BTG
-0.09%
$5.17
AMC
-5.19%
$2.74
RGTZ
+24.38%
$19.41
WLGS
-5.57%
$0.04
JOBY
-6.60%
$15.03
SMR
-13.50%
$33.18
AAPL
-2.46%
$256.27
CLSK
-11.68%
$16.57
BMNR
-9.21%
$47.07
OKLO
-17.73%
$114.71
UUUU
+5.33%
$21.72
NDLS
+34.74%
$0.97
AMZN
-2.27%
$216.98
ETWO
0.00%
$3.30
VIVK
+12.43%
$0.25
HOOD
-7.45%
$122.01
WULF
-5.12%
$13.14
RIVN
-2.61%
$12.85
HPE
-2.48%
$22.69
GOOGL
-0.05%
$250.32
AFMD
-34.94%
$0.18
SNAP
-1.78%
$7.71
SMCI
-7.88%
$50.49
NEHC
-23.22%
$4.33
GSIT
+19.24%
$12.95
IBIO
+14.40%
$1.26
EOSE
-10.24%
$14.63
NBIS
-6.89%
$97.09
YYAI
+88.87%
$0.15
BYND
+14.88%
$4.15
VHAI
0.00%
$0.00
BURU
+26.83%
$0.36
ADAP
+40.53%
$0.06
YDKG
+4.40%
$0.05
F
-1.91%
$12.31
AIRE
+17.02%
$0.85
BENF
+125.66%
$1.09
CGBS
-39.47%
$0.03
DNUT
+13.05%
$4.19
BITF
-15.14%
$3.81
NVDA
-1.95%
$177.61
PLUG
-9.59%
$2.82
RGTI
-12.07%
$35.17
DNN
-2.20%
$2.66
WTO
+5.70%
$0.07
TLRY
-3.06%
$1.43
EPWK
+10.53%
$0.07
CLF
-17.24%
$13.39
AXDX
-61.36%
$0.03
T
-2.40%
$25.42
INTC
-4.61%
$36.36
RANI
-11.22%
$2.52
QBTS
-15.40%
$27.23
BNBX
+47.40%
$5.04
SOFI
-7.37%
$26.63
IXHL
-1.62%
$0.35
RIG
+1.35%
$3.35
TSLA
-2.63%
$430.92
NOK
-1.52%
$5.49
CAN
-12.82%
$1.70
CIFR
-14.77%
$15.40
BBD
-0.45%
$3.28
QUBT
-7.40%
$16.00
ETHD
+10.08%
$4.09
ABEV
-1.35%
$2.19
AMD
-4.45%
$227.43
ONDS
-8.06%
$6.60
IREN
-8.10%
$50.72
PLTR
-5.65%
$171.25
RF
-1.25%
$24.05
GPUS
-3.13%
$0.35
NVTS
-14.87%
$12.79
QS
-13.72%
$13.38
ACHR
-8.80%
$10.40
AAL
-1.98%
$12.10
AREB
+48.40%
$1.85
IONZ
+20.92%
$4.97
RMBL
+60.50%
$3.21
ALEC
-47.81%
$1.67
GPRO
+4.31%
$2.29
NIO
-1.00%
$6.73
GRAB
-1.16%
$5.53
ADD
-25.47%
$0.05
WBD
+1.32%
$20.60
RXRX
-7.20%
$5.67
CJET
+14.21%
$0.09
VALE
+1.92%
$11.48
SRM
+53.27%
$10.30
APLD
-9.37%
$29.49
RR
-15.54%
$4.75
LAES
-14.11%
$5.23
FLWS
-12.33%
$4.51
AVDL
+3.87%
$18.56
SOUN
-6.50%
$17.04
DVLT
-14.82%
$2.15
PFE
-0.52%
$24.72
BTBT
-9.68%
$3.49
MARA
-7.38%
$18.58
CUTR
-10.19%
$0.09
IONQ
-11.17%
$52.85
BTG
-0.09%
$5.17
AMC
-5.19%
$2.74
RGTZ
+24.38%
$19.41
WLGS
-5.57%
$0.04
JOBY
-6.60%
$15.03
SMR
-13.50%
$33.18
AAPL
-2.46%
$256.27
CLSK
-11.68%
$16.57
BMNR
-9.21%
$47.07
OKLO
-17.73%
$114.71
UUUU
+5.33%
$21.72
NDLS
+34.74%
$0.97
AMZN
-2.27%
$216.98
ETWO
0.00%
$3.30
VIVK
+12.43%
$0.25
HOOD
-7.45%
$122.01
WULF
-5.12%
$13.14
RIVN
-2.61%
$12.85
HPE
-2.48%
$22.69
GOOGL
-0.05%
$250.32
AFMD
-34.94%
$0.18
SNAP
-1.78%
$7.71
SMCI
-7.88%
$50.49
NEHC
-23.22%
$4.33
GSIT
+19.24%
$12.95
IBIO
+14.40%
$1.26
EOSE
-10.24%
$14.63
NBIS
-6.89%
$97.09
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.